- Home
- ALT vs KRNY Comparison
ALT vs KRNY Comparison
Compare ALT & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | KRNY |
|---|---|---|
| Founded | 1997 | 1884 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 573.8M | 603.5M |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ALT | KRNY |
|---|---|---|
| Price | $3.20 | $9.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $17.67 | $9.25 |
| AVG Volume (30 Days) | ★ 3.3M | 547.6K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 5.45% |
| EPS Growth | 25.37 | ★ 35.71 |
| EPS | N/A | ★ 0.57 |
| Revenue | $41,000.00 | ★ $2,580,000.00 |
| Revenue This Year | N/A | $3.89 |
| Revenue Next Year | N/A | $17.52 |
| P/E Ratio | ★ N/A | $16.93 |
| Revenue Growth | ★ 105.00 | 36.00 |
| 52 Week Low | $2.56 | $6.23 |
| 52 Week High | $6.44 | $10.24 |
Technical Indicators
Market Signals| Indicator | ALT | KRNY |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 42.13 |
| Support Level | $3.18 | $9.43 |
| Resistance Level | $3.32 | $9.80 |
| Average True Range (ATR) | 0.13 | 0.23 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 33.03 | 13.92 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.